A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma
Public ClinicalTrials.gov record NCT06644924. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Double-blind, Single-dose, Placebo-controlled, 3-Period, 3-Treatment, Crossover, Multicenter Study to Compare the Bronchodilatory Effect and Safety of PT007 to Placebo MDI and Open-Label Ventolin® Evohaler in Adult Participants With Asthma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Phase II study, to investigate the therapeutic efficacy and safety of inhaled PT007 (referred to as AS MDI) compared with placebo MDI and open-label Ventolin Evohaler in male and female participants aged 18 to 65 years (inclusive) with asthma. This study consists of a screening/run-in period, a treatment period, and a follow-up phone call.
Study identification
- NCT ID
- NCT06644924
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 118 participants
Conditions and interventions
Conditions
Interventions
- Intervention: AS MDI Combination Product
- Intervention: Ventolin Evohaler Combination Product
- Intervention: Placebo matching AS MDI Combination Product
Combination Product
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 10, 2025 (Actual)
- Primary completion
- Jun 4, 2025 (Actual)
- Completion
- Jun 4, 2025 (Actual)
- Last update posted
- Aug 27, 2026
2025
United States locations
- U.S. sites
- 22
- U.S. states
- 8
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Encinitas | California | 92024 | — |
| Research Site | Lancaster | California | 93534 | — |
| Research Site | Los Angeles | California | 90048 | — |
| Research Site | Newport Beach | California | 92663 | — |
| Research Site | San Diego | California | 92123 | — |
| Research Site | San Jose | California | 95117 | — |
| Research Site | Stockton | California | 95207 | — |
| Research Site | Clearwater | Florida | 33765 | — |
| Research Site | Miami | Florida | 33175 | — |
| Research Site | Tallahassee | Florida | 32308 | — |
| Research Site | Tampa | Florida | 33607 | — |
| Research Site | White Marsh | Maryland | 21162 | — |
| Research Site | Columbia | Missouri | 65203 | — |
| Research Site | Saint Charles | Missouri | 63301 | — |
| Research Site | St Louis | Missouri | 63141 | — |
| Research Site | Raleigh | North Carolina | 27607 | — |
| Research Site | Medford | Oregon | 97504 | — |
| Research Site | Portland | Oregon | 97202 | — |
| Research Site | Austin | Texas | 78759 | — |
| Research Site | El Paso | Texas | 79912 | — |
| Research Site | Victoria | Texas | 77901 | — |
| Research Site | Milwaukee | Wisconsin | 53228 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06644924, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 27, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06644924 live on ClinicalTrials.gov.